Hickey H, Makdissi M, Hyland R, Wilks D, Dusting G J
Department of Physiology, University of Melbourne, Parkville, Victoria, Australia.
J Mol Cell Cardiol. 1996 Sep;28(9):1985-94. doi: 10.1006/jmcc.1996.0191.
An atheroma-like neo-intima was produced by positioning a flexible collar around the common carotid arteries of normocholesterolaemic rabbits. Vessel segments taken from the mid-region of the collared and control region of the same artery were studied 7 days after surgery. Placebo rabbits were provided ab libitum with regular tap water, and treated animals were supplied with water containing perindopril (0.3 mg/kg/day) for 14 days. Perindopril treatment reduced plasma angiotensin converting enzyme (ACE) activity by 88%, but did not significantly alter arterial blood pressure or heart rate. In control rings from placebo rabbits perindoprilat in vitro (0.1-1.0 microM) reduced the sensitivity to angiotension I up to 20-fold but did not affect that of angiotensin II. In placebo rabbits, the collared arterial segments were approximately five-fold more sensitive to the vasoconstrictor action of 5-HT (P < 0.05) than the corresponding control segments. Perindopril treatment did not prevent the supersensitivity of the collared vessels to 5-HT. Development of the lesion in placebo or perindopril-treated rabbits did not alter the vascular sensitivity to either angiotensin I (10(-9)-10(-5)M) or angiotensin II (10(-10)-10(-6)M). The vasorelaxant action of sodium nitroprusside was similar in collared and control rings, whereas the maximum endothelium-dependent vasorelaxant response to acetylcholine was reduced from 68 +/- 5% in control rings, to 44 +/- 8% (mean +/- S.E.M., n = 9, P < 0.05) in collared rings of placebo-treated rabbits. In the perindopril-treated animals, this impairment of relaxation was restored in collared vessels and was no longer significantly different from the control sections. In contrast, perindoprilat in vitro (1.0 microM) did not alter the vasorelaxant response to acetylcholine in control or collared rings in a separate series of placebo rabbits. Morphologically, vessel segments taken from the centre of the collared artery of all placebo rabbits showed a thickened intima filled with cells that had the appearance of synthetic-state smooth muscle. The intimal/medial cross-sectional area ratio was reduced from 0.11 +/- 0.02 (n = 10) in placebo rabbits to 0.05 +/- 0.01 (n = 9) in perindopril-treated rabbits, whereas cross-sectional area of media of the collared vessels was similar in the two groups. Thus ACE may have important roles in the initiation and progression of atheroma-like lesions. Inhibition of ACE with perindopril reduces intimal thickening and restores the defective vasodilatation induced by the endothelial-dependent vasodilator, acetylcholine.
通过在正常胆固醇血症兔子的颈总动脉周围放置一个柔性套环,产生了动脉粥样瘤样新生内膜。在手术后7天,研究取自同一动脉套环区域中部和对照区域的血管段。安慰剂组兔子随意饮用普通自来水,治疗组动物饮用含培哚普利(0.3毫克/千克/天)的水14天。培哚普利治疗使血浆血管紧张素转换酶(ACE)活性降低了88%,但未显著改变动脉血压或心率。在安慰剂组兔子的对照血管环中,体外培哚普利拉(0.1 - 1.0微摩尔)使对血管紧张素I的敏感性降低达20倍,但不影响对血管紧张素II的敏感性。在安慰剂组兔子中,套环动脉段对5 - HT的血管收缩作用的敏感性比相应对照段高约五倍(P < 0.05)。培哚普利治疗并未预防套环血管对5 - HT的超敏反应。安慰剂组或培哚普利治疗组兔子病变的发展并未改变血管对血管紧张素I(10^(-9) - 10^(-5)摩尔)或血管紧张素II(10^(-10) - 10^(-6)摩尔)的敏感性。硝普钠的血管舒张作用在套环血管和对照血管环中相似,而安慰剂治疗组兔子套环血管中对乙酰胆碱的最大内皮依赖性血管舒张反应从对照血管环中的68±5%降低至44±8%(平均值±标准误,n = 9,P < 0.05)。在培哚普利治疗的动物中,套环血管中这种舒张功能障碍得以恢复,与对照段不再有显著差异。相比之下,在另一组安慰剂兔子中,体外培哚普利拉(1.0微摩尔)并未改变对照血管环或套环血管环中对乙酰胆碱的血管舒张反应。形态学上,所有安慰剂组兔子套环动脉中心取出的血管段显示内膜增厚,充满了具有合成状态平滑肌外观的细胞。内膜/中膜横截面积比从安慰剂组兔子的0.11±0.02(n = 10)降至培哚普利治疗组兔子的0.05±0.01(n = 9),而两组套环血管的中膜横截面积相似。因此,ACE可能在动脉粥样瘤样病变的起始和进展中起重要作用。用培哚普利抑制ACE可减少内膜增厚,并恢复由内皮依赖性血管舒张剂乙酰胆碱诱导的舒张功能缺陷。